alamarbio.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $248.57MM
Alamar Biosciences is a biotechnology company that is striving to develop a precision proteomics platform that is used in protein biomarker detection. Their flagship technology platform is called NULISA (Nanoparticle Uninhibited Luminescent Immunoassay), and it aims to help researchers detect protein biomarkers down to attomolar concentrations, or extremely small amounts. Alamar Biosciences seeks to use the NULISA platform to increase the speed of development for new diagnostic tests that can detect diseases early and improve treatment options. Alamar Biosciences founded in 2018 and headquartered in Fremont, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/26/2024 | Series C | $128.27MM | $xx.xx | $409.08MM | Sands Capital, Sherpa Healthcare Partners, Pura Vida Investments | |
Price per Share
$xx.xx
Shares Outstanding
43,079,756
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Sands Capital, Sherpa Healthcare Partners, Pura Vida Investments
|
||||||
10/15/2021 | Series B-Plus | $10MM | $xx.xx | $390.1MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,053,202
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
09/08/2021 | Series B | $80MM | $xx.xx | $312.15MM | Sherpa Healthcare Partners, Morningside Ventures, Samsara Biocapital, Qiming Venture Partners, Illumina Ventures | |
Price per Share
$xx.xx
Shares Outstanding
19,710,738
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Sherpa Healthcare Partners, Morningside Ventures, Samsara Biocapital, Qiming Venture Partners, Illumina Ventures
|
||||||
05/26/2020 | Series A-4 | $14MM | $xx.xx | $72.79MM | Qiming Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
11,786,788
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Qiming Venture Partners
|
||||||
05/26/2020 | Series A-3 | $14MM | $xx.xx | $72.79MM | Qiming Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
13,153,317
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Qiming Venture Partners
|
||||||
05/26/2020 | Series A-2 | $499,997 | $xx.xx | $72.79MM | Qiming Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
521,955
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Qiming Venture Partners
|
||||||
05/26/2020 | Series A-1 | $1.8MM | $xx.xx | $72.79MM | Qiming Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,113,922
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Qiming Venture Partners
|